| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP General Counsel and Secret
1 company
Larosa Joseph J is an EVP General Counsel and Secret at REGN. Recent filings cover 0 purchases and 81 sales. Those positions are worth an estimated $13.9M at current prices.
Our model assigns Larosa Joseph J a middling insider score of 66/100, based on 9 past trades. Over a 12-month horizon, 66.7% of those trades were profitable, with an average 12-month return of +15.4%.
Larosa Joseph J's largest disclosed position is in REGN as EVP General Counsel and Secret, worth about $13.9M. The recent filings there lean toward selling, a net 53,460 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 11, 2024 | REGN Regeneron Pharmaceuticals, Inc. | EVP General Counsel and Secret | Sell10b5-1 | 1,866 | $1,088.95 | $2,031,980.70 | -4.7% | -6.3% | -47.4% | |
| May 21, 2024 | REGN Regeneron Pharmaceuticals, Inc. | EVP General Counsel and Secret | Sell10b5-1 | 1,865 | $994.90 | $1,855,488.50 | -5.1% | +20.4% | -39.2% | |
| Feb 26, 2024 | REGN Regeneron Pharmaceuticals, Inc. | EVP General Counsel and Secret | Sell | 1,000 | $990.00 | $990,000.00 | -2.7% | -1.6% | -26.9% | |
| Feb 22, 2024 | REGN Regeneron Pharmaceuticals, Inc. | EVP General Counsel and Secret | Sell | 1,000 | $967.65 | $967,650.00 | -2.6% | +2.0% | -27.4% | |
| Feb 7, 2024 | REGN Regeneron Pharmaceuticals, Inc. | EVP General Counsel and Secret | Sell | 1,000 | $950.00 | $950,000.00 | -2.5% | +3.4% | -23.1% | |
| Apr 7, 2022 | REGN Regeneron Pharmaceuticals, Inc. | EVP General Counsel and Secret | Sell | 5,114 | $721.10 | $3,687,705.40 | -23.2% | -17.6% | +14.8% | |
| Apr 1, 2022 | REGN Regeneron Pharmaceuticals, Inc. | EVP General Counsel and Secret | Sell | 5,114 | $690.73 | $3,532,373.15 | -18.9% | -14.9% | +18.3% | |
| Aug 23, 2021 | REGN Regeneron Pharmaceuticals, Inc. | EVP General Counsel and Secret | Sale+OE | 3,425 | $661.84 | $2,266,817.02 | -20.6% | -3.5% | -9.7% | |
| Jul 6, 2021 | REGN Regeneron Pharmaceuticals, Inc. | EVP General Counsel and Secret | Sale+OE | 3,398 | $580.00 | $1,970,840.00 | -20.5% | -4.6% | +2.2% | |
| Aug 31, 2020 | REGN Regeneron Pharmaceuticals, Inc. | EVP General Counsel and Secret | Sale+OE | 4,672 | $615.04 | $2,873,466.88 | -24.4% | - | - |